PreComb Therapeutics
Pre-clinical“One of the biggest challenges in cancer research is bridging the gap between preclinical testing and real patient outcomes. PreComb’s approach addresses this challenge by providing patient-relevant, functional models that allow us to test therapies in a way that truly mimics human biology.”
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $2.8M
About
“One of the biggest challenges in cancer research is bridging the gap between preclinical testing and real patient outcomes. PreComb’s approach addresses this challenge by providing patient-relevant, functional models that allow us to test therapies in a way that truly mimics human biology.”
Diagnostics
Funding History
1Total raised:$2.8M
Seed$2.8MMar 15, 2020